Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer

Risk assessment and treatment choice remain a challenge in early non-small-cell lung cancer (NSCLC). Alternative splicing is an emerging source for diagnostic, prognostic and therapeutic tools. Here, we investigated the prognostic value of the actin cytoskeleton regulator hMENA and its isoforms, hME...

Descripción completa

Detalles Bibliográficos
Autores principales: Bria, Emilio, Modugno, Francesca Di, Sperduti, Isabella, Iapicca, Pierluigi, Visca, Paolo, Alessandrini, Gabriele, Antoniani, Barbara, Pilotto, Sara, Ludovini, Vienna, Vannucci, Jacopo, Bellezza, Guido, Sidoni, Angelo, Tortora, Giampaolo, Radisky, Derek C., Crinò, Lucio, Cognetti, Francesco, Facciolo, Francesco, Mottolese, Marcella, Milella, Michele, Nisticò, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294370/
https://www.ncbi.nlm.nih.gov/pubmed/25373410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294370/
https://www.ncbi.nlm.nih.gov/pubmed/25373410

Ejemplares similares